Opendata, web and dolomites

HALODRUGSYN SIGNED

Innovative Strategies towards Halogenated Organic Molecules: From Reaction Design to Application in Drug Synthesis

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 HALODRUGSYN project word cloud

Explore the words cloud of the HALODRUGSYN project. It provides you a very rough idea of what is the project "HALODRUGSYN" about.

halogenated    broadly    salimabromide    am    heteroarenes    goals    unparalleled    precision    equipped    infections    with    engineering    industry    strategies    synthesized    activation    confident    time    platform    outstanding    fluorine    publication    reactions    efficient    setting    carbon    heteroarene    motifs    anti    gained    toolbox    realization    functional    extend    antibiotic    manner    bond    practicability    innovative    installation    elaborated    create    strains    transformations    units    selectivity    structural    resistance    chemistry    antibiotics    fluorinated    efficiency    construction    provides    synthetic    drug    solution    resistant    applicable    drugs    expansion    chemotherapeutics    expertise    natural    valuable    achievements    first    constitute    strategy    arenes    unprecedented    limitations    groundbreaking    molecular    cancer    synthesis    acute    ring    bonds    bacterial    halogen    restrictions    prevent    combat    pharmaceutical    lack    record   

Project "HALODRUGSYN" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITAET INNSBRUCK 

Organization address
address: INNRAIN 52
city: INNSBRUCK
postcode: 6020
website: http://www.uibk.ac.at

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Austria [AT]
 Project website https://www.uibk.ac.at/organic/magauer/index.html.en
 Total cost 1˙496˙664 €
 EC max contribution 1˙496˙664 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2016-STG
 Funding Scheme ERC-STG
 Starting year 2017
 Duration (year-month-day) from 2017-02-01   to  2022-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITAET INNSBRUCK AT (INNSBRUCK) coordinator 1˙425˙986.00
2    LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN DE (MUENCHEN) participant 70˙677.00

Map

 Project objective

Halogenated arenes and heteroarenes have become essential structural motifs of the pharmaceutical industry to create novel drugs against bacterial infections and cancer, and constitute highly valuable functional units in chemistry. Current methods for the installation of carbon-halogen bonds lack efficiency, selectivity, and practicability within the complex molecular setting of drug development processes. These restrictions prevent many potential drugs from being synthesized in a time- and cost-efficient manner. In this project, I aim to address these challenges by engineering a highly elaborated synthetic toolbox that is equipped with novel transformations of unprecedented efficiency, selectivity and practicability. I will apply these transformations to the construction of novel antibiotics against resistant strains and more efficient chemotherapeutics to combat cancer. The first objective is to establish innovative transformations that enable for the first time an efficient access to halogenated arenes. I will accomplish this goal by developing novel ring-expansion reactions and apply them to the first synthesis of the antibiotic salimabromide in order to address the acute problem of antibiotic resistance. Within the second part of this project, I will extend this unique synthetic platform to heteroarenes and establish a groundbreaking method based on carbon-fluorine bond activation. This will represent the first broadly applicable strategy to produce novel fluorinated heteroarene based anti-cancer drugs with unparalleled precision, efficiency and selectivity. Taken together, the realization of these strategies, all of which are unprecedented, provides for the first time a solution for the limitations associated with current methods. With my expertise in synthetic chemistry, which I have gained from my achievements in natural product synthesis, and an outstanding publication record in this research field, I am confident to accomplish these ambitious goals.

 Publications

year authors and title journal last update
List of publications.
2019 Matthias Schmid, Adriana S. Grossmann, Peter Mayer, Thomas Müller, Thomas Magauer
Ring-expansion approaches for the total synthesis of salimabromide
published pages: 3195-3215, ISSN: 0040-4020, DOI: 10.1016/j.tet.2019.03.010
Tetrahedron 75/24 2019-08-29
2017 Raphael Wildermuth, Klaus Speck, Franz-Lucas Haut, Peter Mayer, Bianka Karge, Mark Brönstrup, Thomas Magauer
A modular synthesis of tetracyclic meroterpenoid antibiotics
published pages: , ISSN: 2041-1723, DOI: 10.1038/s41467-017-02061-7
Nature Communications 8/1 2019-06-13
2018 Johannes Feierfeil, Thomas Magauer
De Novo Synthesis of Benzannelated Heterocycles
published pages: 1455-1458, ISSN: 0947-6539, DOI: 10.1002/chem.201705662
Chemistry - A European Journal 24/6 2019-06-13
2018 Matthias Schmid, Adriana S. Grossmann, Klaus Wurst, Thomas Magauer
Total Synthesis of Salimabromide: A Tetracyclic Polyketide from a Marine Myxobacterium
published pages: , ISSN: 0002-7863, DOI: 10.1021/jacs.8b06228
Journal of the American Chemical Society 2019-06-13
2017 Raphael Ernst Wildermuth, Tatjana Huber, Thomas Magauer
9-Membered Carbocycles: Strategies and Tactics for their Synthesis
published pages: , ISSN: 0947-6539, DOI: 10.1002/chem.201705919
Chemistry - A European Journal 2019-06-13

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HALODRUGSYN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "HALODRUGSYN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

GelGeneCircuit (2020)

Cancer heterogeneity and therapy profiling using bioresponsive nanohydrogels for the delivery of multicolor logic genetic circuits.

Read More  

MATCH (2020)

Discovering a novel allergen immunotherapy in house dust mite allergy tolerance research

Read More  

BECAME (2020)

Bimetallic Catalysis for Diverse Methane Functionalization

Read More